AU2022408173A1 - Bacillus megaterium strain, compositions thereof, and methods of use - Google Patents

Bacillus megaterium strain, compositions thereof, and methods of use Download PDF

Info

Publication number
AU2022408173A1
AU2022408173A1 AU2022408173A AU2022408173A AU2022408173A1 AU 2022408173 A1 AU2022408173 A1 AU 2022408173A1 AU 2022408173 A AU2022408173 A AU 2022408173A AU 2022408173 A AU2022408173 A AU 2022408173A AU 2022408173 A1 AU2022408173 A1 AU 2022408173A1
Authority
AU
Australia
Prior art keywords
renuspore
bacillus megaterium
bacillus
strain
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022408173A
Other languages
English (en)
Inventor
John Deaton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deerland Probiotics & Enzymes Inc
Original Assignee
Deerland Probiotics & Enzymes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deerland Probiotics & Enzymes Inc filed Critical Deerland Probiotics & Enzymes Inc
Publication of AU2022408173A1 publication Critical patent/AU2022408173A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/11—Bacillus megaterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
AU2022408173A 2021-12-08 2022-12-08 Bacillus megaterium strain, compositions thereof, and methods of use Pending AU2022408173A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE20210211 2021-12-08
IE2021/0211 2021-12-08
PCT/US2022/081191 WO2023108077A1 (en) 2021-12-08 2022-12-08 Bacillus megaterium strain, compositions thereof, and methods of use

Publications (1)

Publication Number Publication Date
AU2022408173A1 true AU2022408173A1 (en) 2024-06-20

Family

ID=85158617

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022408173A Pending AU2022408173A1 (en) 2021-12-08 2022-12-08 Bacillus megaterium strain, compositions thereof, and methods of use

Country Status (10)

Country Link
US (1) US20250170189A1 (https=)
EP (1) EP4444862A1 (https=)
JP (1) JP2024546089A (https=)
KR (1) KR20240145458A (https=)
CN (1) CN119948147A (https=)
AU (1) AU2022408173A1 (https=)
CA (1) CA3239844A1 (https=)
MX (1) MX2024006843A (https=)
WO (1) WO2023108077A1 (https=)
ZA (1) ZA202404360B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118185813A (zh) * 2024-03-15 2024-06-14 宜宾五粮液股份有限公司 普利斯特氏菌及其应用
CN119331870A (zh) * 2024-11-11 2025-01-21 暨南大学 核酸分子、转录元件、表达载体、宿主及其应用
CN119351379B (zh) * 2024-12-11 2025-10-31 昆明理工大学 一种普鲁兰酶PulW310B及其在合成高聚合度麦芽寡糖中的用途
CN119979572A (zh) * 2024-12-31 2025-05-13 湖南农业大学 一种保护农作物免遭精喹禾灵药害的降解基因及其应用
CN121555469A (zh) * 2026-01-23 2026-02-24 江苏海洋大学 一种聚对苯二甲酸乙二醇酯水解酶PmPETase及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020109480A1 (en) * 2018-11-30 2020-06-04 Evonik Operations Gmbh Preparation for use to increase the formation of one or more specialized pro-resolving lipid mediators (spm)
US11160838B2 (en) * 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions
US12365869B2 (en) * 2023-06-20 2025-07-22 Tenfold Technologies, LLC Systems for production of products to promote nitrogen use efficiency in plants

Also Published As

Publication number Publication date
CA3239844A1 (en) 2023-06-15
US20250170189A1 (en) 2025-05-29
ZA202404360B (en) 2025-09-25
KR20240145458A (ko) 2024-10-07
MX2024006843A (es) 2024-08-19
JP2024546089A (ja) 2024-12-17
WO2023108077A1 (en) 2023-06-15
EP4444862A1 (en) 2024-10-16
CN119948147A (zh) 2025-05-06

Similar Documents

Publication Publication Date Title
US20250170189A1 (en) Bacillus megaterium strain, compositions thereof, and methods of use
EP2134833B1 (en) Probiotic bifidobacterium strain
JP5693232B2 (ja) グルテン摂取に関連する障害を有する個々の患者の健康向上のための微生物
KR101840239B1 (ko) 장 염증의 치료에 사용하기 위한 프로바이오틱 조성물
JP6587614B2 (ja) プロバイオティクスとしてのラクトバチルス属の菌株
Contaldo Use of probiotics for oral candidiasis: state of the art and perspective. A further step toward personalized medicine?
US20220323390A1 (en) Dietary supplement to promote gut health
US20250170188A1 (en) Bacillus clausii strain, compositions thereof, and methods of use
US20250161374A1 (en) Bacillus coagulans strain, compositions thereof, and methods of use
US9387229B2 (en) Reuterin-producing Lactobacillus brevis
Arora et al. Therapeutic potential of probiotics: A ray of hope or nightmare?
Gupta et al. Synbiotics: promoting gastrointestinal health
Stamatova Probiotic activity of Lactobacillus delbrueckii subsp. bulgaricus in the oral cavity
Alzubaidi Exploration of Beneficial Effects of Urolithins on Obesity Altered Gut Microbiota
HK40104391A (en) Treatment of clostridium difficile infection
Gupta et al. 5 Synbiotics: Promoting Gastrointestinal Health
Unger et al. Probiotics and Health Claims Related to OTC Products and Pharmaceutical Preparations
IE86045B1 (en) Probiotic bifidobacteria strains
IE20080245A1 (en) Probiotic Bifidobacteria strains